Syntegon launches AIM9 platform to transform pharmaceutical vial inspection

The platform integrates visual inspection capabilities with advanced leak detection technology, processing up to 600 vials per minute while maintaining rigorous quality standards.

GERMANY—Syntegon has unveiled its latest innovation in pharmaceutical manufacturing technology with the launch of the AIM9 inspection platform.

Drawing on decades of industry expertise and field-tested engineering, the company designed this system to address the growing demands of pharmaceutical manufacturers and contract manufacturing organizations (CMOs) worldwide.

The platform integrates visual inspection capabilities with advanced leak detection technology, processing up to 600 vials per minute while maintaining rigorous quality standards.

Meeting the speed demands of modern pharma production

Bernd Barkey, President of Syntegon Japan and Global Head of Inspection, emphasized the critical role of efficiency in today’s pharmaceutical landscape.

He explained that the new AIM9 enables customers to significantly increase their productivity while simultaneously meeting ambitious delivery schedules.

The platform’s high-speed processing capabilities make it particularly valuable for manufacturers facing tight production timelines and growing market demands.

The automated inspection system targets high-performance manufacturing environments where speed cannot compromise quality.

The platform’s ability to handle 600 containers per minute positions it as a competitive solution for large-scale pharmaceutical operations that require both high throughput and exceptional defect-detection accuracy.

Flexibility for diverse production needs

Pharmaceutical manufacturers and CMOs frequently face the challenge of managing multiple product lines with varying container specifications.

Syntegon addressed this operational complexity by engineering the AIM9 with enhanced versatility at its core.

The platform accommodates vial sizes ranging from 2 milliliters to 250 milliliters, providing manufacturers with the flexibility to switch between different products without extensive downtime.

The system’s design prioritizes quick changeovers, allowing production teams to adapt rapidly when introducing new products or adjusting to different container formats.

This adaptability proves particularly valuable for CMOs managing diverse client portfolios or manufacturers expanding their product offerings.

Integrated container closure integrity testing

The AIM9 platform introduces a significant advancement in pharmaceutical inspection technology through its fully integrated Container Closure Integrity Testing (CCIT) capabilities.

Unlike conventional systems that require separate equipment for leak detection, this platform incorporates headspace gas analysis and high-voltage leak detection directly into its design.

Manufacturers can select either technology individually or implement both simultaneously, depending on their specific quality assurance requirements.

This integration eliminates the need for additional machinery, reducing both floor space requirements and capital equipment investments while streamlining the overall inspection workflow.

Advanced detection technology

Syntegon equipped the AIM9 with a comprehensive suite of visual inspection technologies designed to identify both particle contamination and cosmetic defects.

The system incorporates the company’s patented SD technology alongside area and line-scan cameras, creating multiple layers of defect detection.

Manufacturers can further enhance the platform’s capabilities by integrating deep learning algorithms that continually improve detection accuracy.

The platform also features a bubble-masking tool that uses sophisticated algorithms to distinguish between harmless air bubbles and genuine product defects.

This intelligent discrimination significantly reduces false rejection rates, helping manufacturers minimize product waste while maintaining strict quality standards.

Proven reliability with modern innovation

Syntegon built the AIM9 platform on a transport system that has demonstrated reliability across numerous customer installations globally.

This proven foundation ensures safe, stable container handling at every stage of the inspection process, reducing the risk of breakage or contamination during quality checks.

Barkey highlighted the company’s extensive experience as a key advantage in developing the platform.

He noted that Syntegon can deliver precisely what customers need to achieve their performance, efficiency, and flexibility targets.

The AIM9 is available in several configurations based on a standardized platform architecture, allowing the company to collaborate with customers in creating customized solutions that address their unique operational requirements.

 

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on LinkedIn for updates.

Visited 50 times, 1 visit(s) today

Newer Post

Thumbnail for Syntegon launches AIM9 platform to transform pharmaceutical vial inspection

Libya eliminates trachoma as a public health problem

Older Post

Thumbnail for Syntegon launches AIM9 platform to transform pharmaceutical vial inspection

Hlther signs MoU with Tapy to revolutionize UAE healthcare with MBRIF support

Be the first to leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *